Earlier Publications

Sort by: Date | Author | Title

Laursen, T., Mindeholm, L., Haemmerle, S., Ferreira, A., Jørgensen, J. O. L., Azria, M. & Christiansen, J. S. (2007). A novel oral preparation of human growth hormone (hGH) is absorbed and increases serum IGF-I levels after 7 days administration to GH-deficient adults. In Clinical - Physiology & Pharmacology of the Growth Hormone Axis: New Treatment Modalities & Indications US Endocrine Society.

Petersen, A. H., Kohler, G., Korsatko, S., Wutte, A., Wonisch, M., Jeppesen, OK., Sparre, T., Clauson, P., Laursen, T., Wollmer, P. & Pieber, T. R. (2007). The effect of exercise on the absorption of inhaled human insulin via the AERx(R) iDMS in people with type 1 diabetes. Diabetes Care, 30(10), 2571-2576.

Østergård, T., Jessen, N., Schmitz, O. & Mandarino, L. J. (2007). The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new? Appl. Physiol. Nutri. Metab., 32, 541-8.

Petersen, A. H., Laursen, T., Ahrén, B., Pieber, T., Clauson, P. & Wollmer, P. (2007). The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits. Eur J Pharm Sci, 30(3-4), 351-357.

Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F. & Goodyear, L. J. (2006). Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle. Diabetes, 55(7), 2067-2076.

Jørgensen, J. O. L., Jessen, N., Pedersen, S. B., Vestergaard, E. T., Gormsen, L. C., Lund, S. & Billestrup, N. (2006). GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am. J. Physiol. Endocrinol. Metab., 291(5), E899-905.

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis. J. Hepatol., 45((6)), 797-804.

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis. Abstract from Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis, 42nd EASD Annual Meeting, Denmark.

Stochholm, K., Gravholt, C. H., Laursen, T., Jørgensen, J. O. L., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M. & Green, A. (2006). Incidence of GH deficiency: a nationwide study. European Journal of Endocrinology, 155(1), 61-71.

Witczak, C. A., Hirshman, M. F., Jessen, N., Fujii, N., Seifert, M. M., Brandauer, J., Hotamisligil, G. S. & Goodyear, L. J. (2006). JNK1 deficiency does not enhance muscle glucose metabolism in lean mice. Biochem. Biophys. Res. Commun., 350(4), 1063-1068.

Husted, S., Ziegler, B. K. & Kher, A. (2006). Long-term anticoagulant therapy in patients with coronary artery disease. European Heart Journal, 27, 913-19.

T., L., Hansen, B. & Fisker, S. (2006). Pain perception after subcutaneous injections of media containing different buffers. Basic Clin. Pharmacol. Toxicol., 98(2), 218-221.

Marier, J.-F., Lor, M., Potvin, D., Dimarco, M., Morelli, G. & Saedder, E. A. (2006). Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. The Journal of Clinical Pharmacology, 46(6), 642-53. https://doi.org/10.1177/0091270006286901

Pedersen, L. H. (2006). Pharmacological Treatment of Depression during Pregnancy. Poster session presented at PhD day 2006, Faculty of Health, University of Aarhus, Denmark.

Kramer, H. F., Witczak, C. A., Hirshmann, M. F., Fujii, N., Jessen, N., Ho, R., Sakamoto, K., Lienhard, G. E. & Goodyear, L. J. (2006). Rab-GAP AS160 is differentially regulated by multiple effectors of glucose transport in mouse skeletal muscle. In Ikke angivet (pp. A1280-A1280). FASEB JOURNAL.

Koh, H.-J., Arnolds, D. E., Fujii, N., Tran, T. T., Rogers, M. J., Jessen, N., Li, Y., Liew, C. W., Ho, R. C., Hirshman, M. F., Kulkarni, R. N., Kahn, C. R. & Goodyear, L. J. (2006). Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Molecular and Cellular Biology, 26(22), 8217-27. https://doi.org/10.1128/MCB.00979-06

Fujii, N., Jessen, N. & Goodyear, L. J. (2006). The Role of AMPK in Glucose Uptake. Am. J. Physiol. Endocrinol. Metab., 291(5), E867-877.

Kramer, H. F., Fujii, N., Ho, R. C., Witczak, C. A., Jessen, N., Hirshman, M. F., Lienhard, G. E. & Goodyear, L. J. (2005). AS160 regulates contraction-stimulated glucose transport in mouse skeletal muscle. Abstract from American Heart Association's Scientific Sessions 2005, Dallas, TX, USA , United States.

Jessen, N. & Goodyear, L. J. (2005). Contraction signaling to glucose transport in skeletal muscle. J. Appl. Physiol., 99, 330-337.

Jessen, N., Djurhuus, C. B., Jorgensen, J. O., Jensen, L. S., Møller, N., Lund, S. & Schmitz, O. (2005). Evidence against a role for insulin-signaling proteins PI3-kinase and Akt in insulin resistance in human skeletal muscle induced by short term GH-infusion. Am. J. Physiol. Endocrinol. Metab., (288(1)), 194-199.

Witczak, C., Jessen, N., Hotamisligil, G. S., Hirshman, M. F. & Goodyear, L. J. (2005). JNK1 deficiency enhances whole body glucose metabolism, but not via alterations in skeletal muscle. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA , United States.

Jessen, N., Koh, H. J., Arnolds, D. E., Mukai, N., Hirshman, M. F., Fujii, N. & Goodyear, L. J. (2005). LKB1 is-a critical regulator of AMPK in heart. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA , United States.

Pold, R., Jensen, L. S., Jessen, N., Buhl, E. S., Schmitz, O., Flyvbjerg, A., Fujii, N., Goodyear, L. J., Gotfredsen, C. F., Brand, C. L. & Lund, S. (2005). Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes, (54(4)), 928-934.

Jørgensen, J. O. L., Vestergaard, E. T., Gormsen, L. C., Jessen, N., Nørrelund, H., Christiansen, J. S. & Møller, N. (2005). Metabolic consequences of GH deficiency. J. Endocrinol. Invest., 28, 47-51.

Jensen, L. S., Nielsen, J. M., Loefgren, B., Kristiansen, S. B., Jessen, N., Nielsen, T. T., Bøtker, H. E., O., S. & Lund, S. (2005). Metformin activates AMP-activated protein kinase (AMPK) in the rat heart and reduces myocardial infarct size 24 hours later. Abstract from 41st EASD Meeting, Athens, Greece, Greece.

Buhl, C., Buhl, E. S., Petersen, C. N., Jessen, N., O., S. & Lund, S. (2005). No inhibitory effect of TNF alpha on insulin-stimulated glucose uptake in in situ skeletal muscle. Abstract from 41st EASD Meeting, Athens, Greece, Greece.

Koh, H. J., Hirshman, M. F., Fujii, N., Arnolds, D. E., Rogers, M. J., Mukai, N., Jessen, N., Ho, R. C. & Goodyear, L. J. (2005). Skeletal muscle-specific knockout of LKB1 causes AICAR resistance but improves glucose tolerance. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA, United States.

Lihn, A. S., Jessen, N., Richelsen, B., Pedersen, S. B. & Lund, S. (2004). AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochen Biophys Res Commun, 316, 853-858.

Laursen, T. (2004). Clinical pharmacological aspects of growth hormone administration. Growth. Horm. IGF. Res., (14(1)), 16-44.

Laursen, T. (2004). Clinical pharmacological aspects of growth hormone administration.

Lindgren, A., Husted, S., Staaf, G. & Ziegler, B. (2004). Dipyridamole and headache - a pilot study of initial dose titration. J Neurol Sci, 223, 179-184.

Lindgren, A., Husted, S., Staaf, G. & Ziegler, B. K. (2004). Dipyridamole and headache - a pilot study of initial dose titration. J Neur Sci, 223, 179-184.

Husted, S. & Ziegler, B. K. (2004). Evidence for the benefits of the low-molecular-weight heparin dalteparin in “high-risk” patients with acute coronary syndromes. Cardiology, 4, 157-163.

Husted, S. & Ziegler, B. (2004). Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in "High-Risk" Patients with Acute Coronary Syndromes. Cardiology, 4, 157-163.

Jørgensen, J. O. L., Krag, M., Jessen, N., Nørrelund, H., Vestergaard, E. T., Møller, N. & Christiansen, J. S. (2004). Growth hormone and glucose homeostasis. Hormone Research, 62(Suppl. 3), 51-55.

Kappelgaard, A. A., Bojesen, A., Skydsgaard, K., Sjögren, I. & Laursen, T. (2004). Liquid Growth Hormone: Preservatives and Buffers. Hormone Research, 62(Suppl.3), 1197-16.

Chen, J. W., Ledet, T., Ørskov, H., Jessen, N., Lund, S., Whittaker, J., De Meyts, P., Larsen, M. B., Christiansen, J. S. & Frystyk, J. (2003). A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am. J. Physiol. Endocrinol. Metab., 284(6), 1149-1155.

Ziegler, B. K., Rasmussen, L. H., Kristensen, S. D., Hildebrandt, P. R., Nielsen, H. K. & Husted, S. E. (2003). Clopidogrel: baggrundsinformation og anvendelse i klinisk praksis. Ugeskrift for Læger, 165, 1859-1863.

Ziegler, B. K., Rasmussen, L. H., Kristensen, S. D., Hildebrandt, P. R., Nielsen, H. K. & Husted, S. (2003). Clopidogrel: baggrundsinformation og anvendelse i klinisk praksis. Ugeskrift for Læger, 165, 1859-1863.

Pedersen, L. H., Stoltenberg, M., Ernst, E. & West, M. J. (2003). Leydig cell death in rats exposed to bismuth subnitrate. Journal of Applied Toxicology, 23(4), 235-238. https://doi.org/10.1002/jat.912

Laursen, T. (2003). Pharmacological properties of a long-acting preparation of growth hormone. International Growth Monitor, 13(2), 11-13.

Laursen, T., Jørgensen, J. O. L. & Christiansen, J. S. (2002). Aktuelle og potentielle indikationer for behandling med væksthormon (GH). Medicus, 6, 1197-16.

Pedersen, L. H., Stoltenberg, M. & Ernst, E. (2002). Attitudes among sperm donors in 1992 and 2002. Poster session presented at Nordic Conference of Obstetrics and Gynecology, Umeå, Sweden.

Pedersen, L. H. (2002). Decreased number of Leydig cells in rats exposed to bismuth: Diploma thesis.

Jessen, N., Pold, R., Buhl, E. S., Jensen, L. S., Schmitz, O. & Lund, S. (2002). Effects of AICAR and Exercise on Insulin-stimulated Glucose Uptake, Insulin Signaling and GLUT4 Content in Rat Skeletal Muscles. J. Appl. Physiol., 20, 0-0.

Buhl, E. S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S. B., Pedersen, O., O., S. & Lund, S. (2002). Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes, 51(7), 2199-2206.

Buhl, E. S., Jessen, N., Schmitz, O., Pedersen, S. B., Pedersen, O., Holman, G. D. & Lund, S. (2001). Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes, 50(1), 12-7.

Ziegler, B. K., Kristensen, S. D., Vissinger, H., Jensen, H. K., Nielsen, H. K. & Husted, S. (2001). Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST-elevation myocardial infarction: A placebo-controlled pilot study. Thromb Res, 104, 175-180.

Laursen, T., Gravholt, C. H., Heickendorff, L., Drustrup, J., Kappelgaard, A. M., Jørgensen, J. O. L. & Christiansen, J. S. (2001). Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoproteinmetabolism in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 86(3), 1222-1228.

Laursen, T., Gravholt, C. H., Heickendorff, L., Drustrup, J., Kappelgaard, A. M., Jørgensen, J. O. L. & Christiansen, J. S. (2001). Long-term effects of continuous subcutaneous (sc) infusion versus daily injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, bone and lipoprotein metabolism inGH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 86, 1222-1228.

Displaying results 251 to 300 out of 302

Revised 15.06.2022

Ellen Kristensen